COLO-RECTAL CANCER (DMMR/MSI-H CRC)
Clinical trials for COLO-RECTAL CANCER (DMMR/MSI-H CRC) explained in plain language.
Never miss a new study
Get alerted when new COLO-RECTAL CANCER (DMMR/MSI-H CRC) trials appear
Sign up with your email to follow new studies for COLO-RECTAL CANCER (DMMR/MSI-H CRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug approach tested before cancer surgery
Disease control Recruiting nowThis study observes how well the drug tislelizumab works when given before surgery to patients with a specific type of stage II or III colorectal cancer. About 30 patients will receive three cycles of the drug, then have surgery, and be followed for five years. The goal is to see…
Matched conditions: COLO-RECTAL CANCER (DMMR/MSI-H CRC)
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Cancer patients choose: quick shot or IV drip?
Symptom relief Recruiting nowThis study asks cancer patients which way they prefer to receive their immunotherapy drugs: as a quick injection under the skin or through a longer IV infusion. Researchers will enroll 480 people with various advanced cancers to compare comfort, convenience, and quality of life b…
Matched conditions: COLO-RECTAL CANCER (DMMR/MSI-H CRC)
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC